Total Payments
$918,172
2024 Payments
$120,241
Companies
40
Transactions
1,375
Medicare Patients
48,238
Medicare Billing
$2.5M
Payment Breakdown by Category
Other$710,015 (77.3%)
Travel$114,690 (12.5%)
Consulting$70,515 (7.7%)
Food & Beverage$21,424 (2.3%)
Research$1,410 (0.2%)
Education$118.26 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $641,993 | 536 | 69.9% |
| Travel and Lodging | $114,690 | 292 | 12.5% |
| Consulting Fee | $70,515 | 33 | 7.7% |
| Compensation for serving as faculty or as a speaker for a medical education program | $44,738 | 34 | 4.9% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $23,285 | 22 | 2.5% |
| Food and Beverage | $21,424 | 452 | 2.3% |
| Unspecified | $1,410 | 1 | 0.2% |
| Education | $118.26 | 5 | 0.0% |
Payments by Type
General
$916,763
1,374 transactions
Research
$1,410
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $587,693 | 810 | $0 (2024) |
| Abbott Laboratories | $124,332 | 169 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $79,530 | 108 | $0 (2019) |
| Novo Nordisk Inc | $69,221 | 94 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $14,829 | 19 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $14,520 | 23 | $0 (2024) |
| ABBVIE INC. | $9,616 | 38 | $0 (2024) |
| Eli Lilly and Company | $7,246 | 19 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $3,720 | 12 | $0 (2020) |
| CeQur Corporation | $3,563 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $120,241 | 183 | Lilly USA, LLC ($84,356) |
| 2023 | $108,514 | 150 | Lilly USA, LLC ($97,590) |
| 2022 | $118,800 | 140 | Lilly USA, LLC ($70,148) |
| 2021 | $80,708 | 97 | Lilly USA, LLC ($40,222) |
| 2020 | $96,737 | 139 | Lilly USA, LLC ($79,312) |
| 2019 | $150,381 | 232 | Lilly USA, LLC ($91,360) |
| 2018 | $129,266 | 245 | Lilly USA, LLC ($80,002) |
| 2017 | $113,525 | 189 | Janssen Pharmaceuticals, Inc ($48,712) |
All Payment Transactions
1,375 individual payment records from CMS Open Payments — Page 1 of 55
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Abbott Laboratories | FREESTYLE LIBRE PRO (Device) | Consulting Fee | Cash or cash equivalent | $2,165.63 | General |
| Category: Diabetes Care | ||||||
| 12/16/2024 | Abbott Laboratories | FREESTYLE LIBRE PRO (Device) | Travel and Lodging | In-kind items and services | $341.22 | General |
| Category: Diabetes Care | ||||||
| 12/15/2024 | Abbott Laboratories | FREESTYLE LIBRE PRO (Device) | Travel and Lodging | In-kind items and services | $872.89 | General |
| Category: Diabetes Care | ||||||
| 12/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,000.00 | General |
| Category: Diabetes Care | ||||||
| 12/12/2024 | Abbott Laboratories | FREESTYLE LIBRE PRO (Device) | Food and Beverage | In-kind items and services | $129.39 | General |
| Category: Diabetes Care | ||||||
| 12/11/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $3,600.00 | General |
| 12/11/2024 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $1,575.00 | General |
| 12/05/2024 | Eli Lilly and Company | — | Travel and Lodging | Cash or cash equivalent | $35.00 | General |
| 12/05/2024 | Eli Lilly and Company | — | Food and Beverage | Cash or cash equivalent | $28.52 | General |
| 12/04/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $16.96 | General |
| 11/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $675.00 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $734.36 | General |
| 11/19/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Diabetes | ||||||
| 11/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,562.50 | General |
| Category: Diabetes Care | ||||||
| 11/14/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Travel and Lodging | In-kind items and services | $1,104.33 | General |
| Category: Diabetes Care | ||||||
| 11/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $107.71 | General |
| Category: Diabetes Care | ||||||
| 11/12/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.52 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $168.37 | General |
| 11/06/2024 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $168.37 | General |
| 11/06/2024 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $151.36 | General |
| 11/06/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $140.00 | General |
| 11/06/2024 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $68.48 | General |
| 11/06/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $53.96 | General |
| 11/06/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $38.37 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Importance of PPG; Post meal glucose, glycemic control and long-term complications | SANOFI-AVENTIS U.S. LLC | $1,410 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 48 | 11,594 | 25,574 | $1.9M | $643,847 |
| 2022 | 51 | 12,383 | 25,016 | $1.9M | $649,864 |
| 2021 | 52 | 12,344 | 25,412 | $2.6M | $693,386 |
| 2020 | 54 | 11,917 | 21,583 | $2.1M | $550,734 |
Total Patients
48,238
Total Services
97,585
Medicare Billing
$2.5M
Procedure Codes
205
All Medicare Procedures & Services
205 procedure records from CMS Medicare Utilization — Page 1 of 9
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 560 | 1,368 | $532,762 | $151,657 | 28.5% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2023 | 563 | 1,333 | $137,565 | $53,799 | 39.1% |
| 82306 | Vitamin d-3 level | Office | 2023 | 564 | 1,328 | $98,275 | $38,438 | 39.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 22 | 1,740 | $87,470 | $32,260 | 36.9% |
| 80418 | Anterior pituitary gland evaluation panel | Office | 2023 | 42 | 51 | $73,884 | $28,962 | 39.2% |
| 84681 | C-peptide (protein) level | Office | 2023 | 558 | 1,275 | $66,329 | $25,936 | 39.1% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 96 | 98 | $77,819 | $23,090 | 29.7% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 116 | 118 | $73,404 | $21,303 | 29.0% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 175 | 178 | $64,555 | $18,961 | 29.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 574 | 1,367 | $45,752 | $17,896 | 39.1% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 529 | 1,074 | $45,486 | $17,795 | 39.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 118 | 220 | $60,621 | $17,243 | 28.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 523 | 1,046 | $43,934 | $17,201 | 39.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 569 | 1,370 | $36,173 | $14,159 | 39.1% |
| 83721 | Ldl cholesterol level | Office | 2023 | 573 | 1,363 | $35,837 | $14,015 | 39.1% |
| 82985 | Glycated protein level | Office | 2023 | 269 | 744 | $31,177 | $12,184 | 39.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 573 | 1,414 | $13,786 | $11,762 | 85.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 54 | 54 | $36,285 | $9,788 | 27.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 530 | 1,077 | $24,288 | $9,503 | 39.1% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 180 | 182 | $21,461 | $8,464 | 39.4% |
| 82523 | Collagen cross links test, (urine test to evaluate bone health) | Office | 2023 | 276 | 436 | $20,361 | $7,983 | 39.2% |
| 83525 | Insulin measurement, total | Office | 2023 | 251 | 673 | $19,226 | $7,515 | 39.1% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 230 | 504 | $19,001 | $7,449 | 39.2% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 102 | 248 | $25,586 | $7,405 | 28.9% |
| 82746 | Folic acid level, serum | Office | 2023 | 228 | 501 | $18,412 | $7,219 | 39.2% |
About Dr. Barbara Hirsch, MD
Dr. Barbara Hirsch, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Manhasset, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679533434.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Barbara Hirsch, MD has received a total of $918,172 in payments from pharmaceutical and medical device companies, with $120,241 received in 2024. These payments were reported across 1,375 transactions from 40 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($641,993).
As a Medicare-enrolled provider, Hirsch has provided services to 48,238 Medicare beneficiaries, totaling 97,585 services with total Medicare billing of $2.5M. Data is available for 4 years (2020–2023), covering 205 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Manhasset, NY
- Active Since 03/24/2006
- Last Updated 02/19/2025
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1679533434
Products in Payments
- TRULICITY (Drug) $307,289
- MOUNJARO (Drug) $201,161
- INVOKANA (Drug) $79,521
- FreeStyle Libre Pro (Device) $55,756
- FREESTYLE LIBRE 3 (Device) $31,681
- RYBELSUS (Drug) $18,068
- Ozempic (Drug) $16,938
- FREESTYLE LIBRE (Device) $16,914
- Rybelsus (Drug) $15,400
- FREESTYLE LIBRE 2 (Device) $11,404
- Synthroid (Drug) $9,544
- Tresiba (Drug) $9,327
- ADLYXIN (Drug) $8,397
- Victoza (Drug) $7,933
- CYCLOSET (Drug) $6,283
- JANUVIA (Drug) $4,980
- STEGLATRO (Drug) $4,770
- SOLIQUA (Drug) $4,416
- CeQur Simplicity (Device) $3,563
- FREESTYLE LIBRE PRO (Device) $3,509
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.